Michael Phoch

Michael Phoch
Americanstocknews - 20 years of experience in mass media

Hepatocellular Carcinoma: European Commission approves Roche’s Tecentriq in combination with Avastin for the treatment of people with the most common form of liver cancer

/

today announced that the European Commission has approved Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab) for the treatment of adult patients with advanced or unresectable hepatocellular carcinoma (HCC) who have not received prior systemic therapy.

More
1 605 606 607 608 609 662